Intelligent Bio Solutions (NASDAQ:INBS) Announces Quarterly Earnings Results

Intelligent Bio Solutions (NASDAQ:INBS) posted its quarterly earnings results on Thursday. The company reported ($0.50) earnings per share (EPS) for the quarter, Zacks reports. Intelligent Bio Solutions had a negative return on equity of 147.50% and a negative net margin of 288.35%.

Intelligent Bio Solutions Price Performance

Shares of NASDAQ:INBS traded down $0.15 during midday trading on Thursday, reaching $2.35. 574,759 shares of the company’s stock were exchanged, compared to its average volume of 222,014. The company’s 50 day simple moving average is $1.53 and its two-hundred day simple moving average is $1.52. Intelligent Bio Solutions has a 12 month low of $1.00 and a 12 month high of $5.87.

About Intelligent Bio Solutions

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.